How Does Prostate Cancer Start and Spread?

Prostate cancer remains one of the most frequently diagnosed malignancies among men worldwide. Yet, unlike cancers that announce themselves through rapid tumor growth or early debilitating pain, prostate cancer is biologically distinct: it often originates as microscopic cellular mutations that progress silently over years, or even decades, before causing detectable symptoms.

Robotic urologic oncologist Dr. David Samadi—pioneer of the SMART (Samadi Modified Advanced Robotic Technique) prostatectomy—frequently emphasizes to patients that understanding how prostate cancer begins and the biological pathways it uses to spread is the single most critical factor in achieving early, curative treatment. When caught while confined to the prostate gland, cancer can be completely excised; once it breaches anatomical boundaries, treatment shifts from local surgical cure to systemic management.

1. How It Starts: The Cellular Origin of Prostate Cancer

The prostate is a walnut-sized gland situated just below the urinary bladder, encircling the upper urethra. Its primary function is producing the nutrient-rich fluid that nourishes and transports sperm.

• Acquired Genetic Mutations: Prostate cancer begins at the microscopic level when DNA mutations disrupt the normal regulatory lifecycle of glandular epithelial cells. Normal prostate cells divide, perform their secretory function, and undergo apoptosis (programmed cell death). Cancerous mutations disable these checkpoint genes, allowing abnormal cells to divide uncontrollably and form small cellular clusters.
• Prostatic Intraepithelial Neoplasia (PIN): Before invasive adenocarcinoma forms, tissue often passes through a precursor phase known as high-grade PIN, where the architecture of the glands becomes irregular but remains bounded by the baseline cellular membrane.
• The Peripheral Zone (The Primary Origin): Approximately 70% to 75% of prostate cancers originate in the peripheral zone—the outer posterior rim of the gland furthest from the urethra. Because early tumors develop on this outer perimeter, they do not compress the urinary channel. As Dr. Samadi points out, this explains why early-stage prostate cancer causes no urinary hesitation, no weak stream, and no pain. The disease develops silently, detectable solely via elevated Prostate-Specific Antigen (PSA) blood levels or an abnormal digital rectal exam (DRE).

2. The Pathways of Spread: How Prostate Cancer Progresses

When prostate cancer cells become more dedifferentiated (reflected in higher Gleason scores, such as Gleason 8, 9, or 10), they produce enzymes called matrix metalloproteinases that dissolve surrounding extracellular matrices, allowing them to invade adjacent structures.

Prostate cancer spreads through three sequential biological pathways:

[PRIMARY PROSTATE TUMOR]

│

├─► 1. LOCAL EXTENSION (Breaches Capsule, Seminal Vesicles, Bladder)

│

├─► 2. LYMPHATIC DISSEMINATION (Obturator, Internal/External Iliac Nodes)

│

└─► 3. HEMATOGENOUS (BLOODSTREAM) SPREAD (Batson’s Plexus to Axial Skeleton)

Phase 1: Local Infiltration (Extracapsular Extension)

As the primary tumor enlarges, it advances through the prostatic stroma toward the outer boundaries of the organ:

• Capsular Breach: The tumor penetrates through the fibrous outer sheath (prostatic capsule) into the periprostatic fat.
• Neurovascular Bundle Invasion: Tumors often track along the low-resistance perineural spaces surrounding the paired cavernous nerve bundles that run along the posterolateral surface of the gland.
• Adjacent Organ Involvement: Advanced local disease directly infiltrates the seminal vesicles, the bladder neck, or the external urethral sphincter.

Phase 2: Regional Lymphatic Dissemination

The prostate is drained by a rich network of lymphatic channels:

• Rogue cancer cells detach from the primary tumor and enter local lymphatic capillaries.
• They first filter into the pelvic lymph node landing zones—specifically the obturator, internal iliac (hypogastric), and external iliac lymph nodes.
• Once cancer establishes a presence in the pelvic lymph nodes, it can travel up the retroperitoneum through common iliac, para-aortic, and distant lymph chains.

Phase 3: Hematogenous Spread (Metastasis to the Bones)

When prostate cancer enters the bloodstream, it displays an affinity for skeletal bone tissue:

• Batson’s Venous Plexus: The pelvic venous system directly communicates with the valveless vertebral venous plexus (Batson’s plexus). This provides a direct, low-pressure vascular route for cancer cells to travel straight from the prostate into the spine, sacrum, and pelvis without needing to pass through the lungs first.
• Osteoblastic Metastases: Prostate cancer bone metastases are characteristically osteoblastic. Cancer cells release factors like endothelin-1 that stimulate abnormal, chaotic new bone formation. This weakens the bone architecture, causing deep gnawing skeletal pain, pathologic fractures, and spinal cord compression.

Stages of Spread: Clinical Progression Matrix

Frequently Asked Questions (FAQ)

How long does it typically take for prostate cancer to spread?

Prostate cancer progression timelines vary widely. Low-grade cancers (Gleason 6) often remain localized for years without significant change. In contrast, high-grade cancers (Gleason 8 to 10) carry aggressive biological mutations that can penetrate the capsule and migrate to lymph nodes or bone within months if left untreated.

Why does prostate cancer target the bones instead of other organs?

Prostate cancer follows the “seed and soil” hypothesis of metastasis. The bone marrow microenvironment is exceptionally rich in growth factors (such as TGF-beta and IGF-1) and extracellular matrix proteins that prostate cancer cells have surface receptors for, providing an ideal biological environment for circulating cancer cells to nest, vascularize, and thrive.

Can surgery still help if the cancer has started to spread locally?

Yes. In locally advanced disease (T3), completely removing the primary tumor through precision robotic surgery debulks the main tumor mass, prevents catastrophic local urinary blockage, and provides accurate pathological staging to guide targeted postoperative salvage radiation or hormone therapy.

Conclusion

Prostate cancer starts quietly in the microscopic architecture of the peripheral gland and spreads through predictable anatomical highways—extending first through the capsule, filtering into regional lymph nodes, and traveling through venous pathways to the skeleton. Because this progression occurs without early warning signs, waiting for pain or urinary blockage before getting checked allows the window for complete surgical cure to narrow. Timely PSA screening, accurate staging, and high-volume robotic surgical expertise remain the strongest defenses against prostate cancer progression.